newsfilter
← Latest News
GlobeNewswire·

Mentari Therapeutics to Present at Upcoming Investor Conferences

WALTHAM, Mass., Nov. 09, 2026 (GLOBE NEWSWIRE) -- Mentari Therapeutics, Inc. (NASDAQ:MTRI), a clinical-stage biotechnology company developing therapies for migraine prevention, today announced that members of